ASHP to develop IV and oral drug standardized concentrations

The FDA awarded the pharmacy group a three-year contract as part of the agency's Safe Use Initiative. More

FDA

New treatment approved for bipolar disorder, schizophrenia

FDA has approved cariprazine (Vraylar) capsules, an atypical antipsychotic, indicated for the treatment of adults with schizophrenia as well as bipolar I disorder. More

EDITOR'S CHOICE

Biosimilars' savings could be lower than predicted

While biosimilars' savings will not reach the historically high level achieved for small-molecule generic drugs, the impact on the healthcare industry will still be significant. More

Inside The Latest Issue

Reinventing your practice Six tips for managing your manager Lowering the risk of PE recurrence

September 24, 2015

Continuing education

MTM essentials for allergic rhinitis management

Primer on Inhalers and nebulizers: August 2015 CPE

MTM essentials for COPD management: Part 2

sponsored link

A Systematic Approach to Weight Loss and Disease Management

Get the free app!

UBM MEDICA